Addus HomeCare Corp (ADUS)

33.40
NASDAQ : Health Care
Prev Close 33.40
Day Low/High 0.00 / 0.00
52 Wk Low/High 24.40 / 40.75
Avg Volume 37.90K
Exchange NASDAQ
Shares Outstanding 11.62M
Market Cap 385.35M
EPS 1.10
P/E Ratio 23.68
Div & Yield N.A. (N.A)

Latest News

Oversold Conditions For Addus HomeCare

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADUS, ARRS, CPHC, CYD, FTS, IVR, LBTYB, LPTH, LSI, LYG, MPG, MTDR, MTG, NVGS, OGS, PCMI, PNRG, POPE, SHLO, TORM, TSEM Downgrades: DAC, DVCR, TBK, TNGO, WWW Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Commit To Purchase Addus HomeCare Corp At $30, Earn 12% Annualized Using Options

Investors considering a purchase of Addus HomeCare Corp shares, but cautious about paying the going market price of $36.08/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $30 strike, which has a bid at the time of this writing of $1.55.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AZN, HZO, IPXL, SCAI, YY Downgrades: ADUS, CS, CSTE, EEI, FDUS, FNV, MDU, MSON, PEGI, TRC Initiations: HYH Read on to get TheStreet Quant Ratings' detailed report:

Relative Strength Alert For Addus HomeCare

Relative Strength Alert For Addus HomeCare

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - NEE, ZINC And ADUS Traded By Insiders

Insider Trading Alert - NEE, ZINC And ADUS Traded By Insiders

Stocks with insider trader activity include NEE, ZINC and ADUS

Oversold Conditions For Addus HomeCare (ADUS)

Oversold Conditions For Addus HomeCare (ADUS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Why Addus (ADUS) Stock Is Surging Today

Why Addus (ADUS) Stock Is Surging Today

Shares of Addus (ADUS) are up after Oppenheimer Holdings upgraded the stock to 'outperform' from 'perform.'

Relative Strength Alert For Addus HomeCare

Relative Strength Alert For Addus HomeCare

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Hated Earnings Stocks You Should Love

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

RSI Alert: Addus HomeCare (ADUS) Now Oversold

RSI Alert: Addus HomeCare (ADUS) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

2 Health Care Stocks Rising on Big Volume

2 Health Care Stocks Rising on Big Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

2 Stocks Spiking on Unusual Volume

2 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Addus Homecare Corporation Stock Upgraded (ADUS)

Addus Homecare Corporation Stock Upgraded (ADUS)

Addus Homecare Corporation (Nasdaq:ADUS) has been upgraded by TheStreet Ratings from a hold to buy.

Addus Homecare Corporation Stock Upgraded (ADUS)

Addus Homecare Corporation Stock Upgraded (ADUS)

Addus Homecare Corporation (Nasdaq:ADUS) has been upgraded by TheStreet Ratings from a sell to hold.

Addus Homecare Corporation Stock Downgraded (ADUS)

Addus Homecare Corporation (Nasdaq:ADUS) has been downgraded by TheStreet Ratings from from a hold to sell.

Addus Homecare Corporation Stock Upgraded (ADUS)

Addus Homecare Corporation (Nasdaq:ADUS) has been upgraded by TheStreet Ratings from a sell to hold.

The Law Office Of Robbins Umeda LLP Announces Investigation Of Addus HomeCare Corp.

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by certain officers and directors at Addus HomeCare Corp.

TheStreet Quant Rating: B (Buy)